AAO 2026 • Advisory Board Meetings
On Thursday, October 8, 2026, Vanguard Ophthalmology Society (VOS) members met with the Carl ZEISS Meditec team to discuss new technology, microscopes, diagnostic, and surgical portfolio.

Excellence in Ophthalmology
Promoting excellence and advancement of ophthalmology through a collaboration of future leaders in our field
On Thursday, October 8, 2026, Vanguard Ophthalmology Society (VOS) members met with the Carl ZEISS Meditec team to discuss new technology, microscopes, diagnostic, and surgical portfolio.

On Thursday, April 9, 2026, Vanguard Ophthalmology Society (VOS) members met with the J&J team during an advisory meeting to discuss the upcoming launch of the TECNIS PureSee IOL. During the session, participants gained valuable insights into the product and collaborated on strategies for a successful launch, including approaches to effectively educate surgical teams.
On Thursday, November 6, 2025, the Vanguard Ophthalmology Society (VOS) held its member meeting. Later that evening, VOS met with the BVI Medical team for dinner at Dante NYC. The discussion focused on upcoming launches, sharing valuable insights to help ensure their success.
VOS met with the Tarsus Therapeutics team to discuss strategies for educating doctors and office staff on available treatments, enhancing proactive understanding of scientific information, and emphasizing the importance of recognizing manifestations, co-morbidities, and symptom frequency in Demodex Blepharitis.